The $140,672,343 man: Why does Brent Saun­ders have the rich­est gold­en para­chute in bio­phar­ma?

Live by the deal, prof­it by the deal.

If any com­pa­ny can suc­ceed where Pfiz­er failed and take over Al­ler­gan, CEO Brent Saun­ders may be per­fect­ly con­tent to step aside. In a new list­ing of the top gold­en para­chutes on record, Bloomberg put the wheel­er-deal­er in the num­ber 5 po­si­tion over­all, with $140,672,343 wait­ing by the ex­it. And that’s the biggest, bright­est gold­en para­chute in bio­phar­ma’s cor­po­rate clos­et.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.